Apontis Pharma AG (APPH) — Capital Reinvestment Ratio
Latest as of December 2024:
0.01x
Apontis Pharma AG (APPH) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow (€905.24K) in capital expenditures (€5.60K). See Apontis Pharma AG free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
€905.24K
EUR
Capital Expenditures
€5.60K
EUR
Data as of
Dec 2024
Most recent filing
Apontis Pharma AG Capital Reinvestment Ratio (2020–2022)
This chart tracks Apontis Pharma AG's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Apontis Pharma AG (2020–2022)
Year-by-year Capital Reinvestment Ratio for Apontis Pharma AG from 2020 to 2022. For live market cap and broader valuation context, see Apontis Pharma AG (APPH) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | €11.02 Million | €3.28 Million | ▼ -38.5% |
| 2021 | 0.48x | €3.43 Million | €1.66 Million | ▼ -3.8% |
| 2020 | 0.50x | €1.45 Million | €729.56K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow